Due to the absence of critical features of the stem cell niche, Mesenchymal Stem Cells (MSCs) often lose their stem cell properties during cell culture on ordinary tissue culture plastic. This makes it difficult to obtain high-quality cells in large numbers.
As a solution, Dr Xiao-Dong Cheng, a tenured professor at UT Health San Antonio, developed CELLvo™ Matrix, an advanced stem cell culture system which replicates the 3-dimensional environment where stem cells naturally reside and proliferate.
This CELLvo™ Matrix allows MSCs to expand quickly, reliably and with less donor variability, while largely maintaining their stem-like properties.
Today, StemBioSys provides CELLvo™ cells, the only cells available that have been isolated and expanded using CELLvo™ Matrix technology, to researchers around the world.
What’s more, until the end of the year, you can get 25% off their CELLvo™ Mesenchymal Stem Cells!
Offer Details
Get 25% off StemBioSys’ CELLvo™ Mesenchymal Stem Cells.
You can claim this offer by mentioning promo code ‘CELLvoQ4MSCs‘ when contacting us.
This offer is valid from 1st October until 31st December 2026.
Offer not valid in conjunction with any other discounts.
About CELLvo™ MSCs
At StemBioSys®, they source all of their cells from young, healthy tissue to ensure you have top-quality cells, and by isolating cells on a cell-derived extracellular matrix, more natural phenotypes are preserved.
All of StemBioSys’ Mesenchymal Stem Cells are isolated and cryopreserved in 100% xeno-free conditions on the CELLvo™ XF Matrix, providing cells that have never come into contact with non-human proteins.
CELLvo™ MSCs proliferate more quickly, have a smaller cell size and show a higher percentage of SSEA4 (+) cells as compared to MSCs isolated and cultured on other substrates.
Although StemBioSys’ products are strictly for research purposes today, they have tremendous potential for clinical use in the future. Rapid expansion of speciality cells and various forms of the CELLvo™ Matrix are positioned to play a key role in many areas of regenerative medicine: cardiology (replacing heart tissue), diabetes (improving production of insulin), osteoarthritis and Parkinson’s disease (repairing damaged nerve tissue) to name a few.
CELLvo™ Human Bone Marrow Mesenchymal Stem Cells
CELLvo™ Human Wharton’s Jelly Mesenchymal Stem Cells
Wharton’s Jelly is a rich source of highly proliferative, multipotent, Mesenchymal Stem Cells. These cells are known to be highly immunomodulatory and capable of trilineage differentiation.
CELLvo™ Human Adipose Mesenchymal Stem Cells
hAD-MSCs are multipotent stem cells, capable of rapid proliferation, trilineage differentiation, and potent immunomodulation, found in abundance in the stromal vascular fraction of adipose tissue. Currently, adipose tissue is the most common source of MSCs in clinical use.
CELLvo™ Amniotic Membrane-Mesenchymal Stromal Cells
CELLvo™ Amniotic membrane mesenchymal stromal cells are isolated from the amniotic membrane of full-term human pregnancies delivered by Caesarean section. These cells are released from the amnion enzymatically and subsequently expanded on CELLvo™ XF Matrix without the use of animal products before cryogenic preservation at passage 2.
Rigorous quality control confirms cell identity by testing for the expression of surface and intracellular markers, and they’re also tested for their ability to undergo osteogenic differentiation.
Amniotic membrane mesenchymal cells share the anti-inflammatory properties of the amniotic membrane. These multipotent cells are studied for their ability to promote angiogenesis and neurogenesis and their potential to attenuate graft-vs-host disease.
About StemBioSys
StemBioSys is located in San Antonio, Texas and is proximate to the University of Texas Health Science Center San Antonio (UTHSC-SA) from which they have licensed proprietary and disruptive technology for the enhanced isolation, growth and delivery of stem cells or other difficult-to-culture cells for research, diagnostic and therapeutic applications.
Their core novel technology platform is an advanced stem cell culture system – CELLvo™ Matrix. CELLvo Matrix™ replicates the 3-dimensional “home” in which stem cells naturally reside and proliferate. Stem cells grown in BM-HPME™ remain small, proliferative and undifferentiated. This unique technology enables users to isolate and grow stem cells and other difficult-to-culture cells from a variety of sources, including but not limited to adipose, bone marrow, umbilical cord blood/tissue and cancer cells.
Stem cells are the future of medicine. StemBioSys is the future of stem cells.
Caltag is the distributor of StemBioSys‘ products in the UK and Ireland.